Skip to content

Head Repositioning Accuracy During Experimental Neck Pain

Neck Pain - Motor and Sensory Aspects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04001218
Enrollment
28
Registered
2019-06-28
Start date
2015-04-09
Completion date
2015-09-22
Last updated
2019-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Neck Pain

Brief summary

This study investigates if/how an experimentally applied neck muscle pain influences head repositioning error in healthy participants.

Detailed description

Healthy volunteers will participate in a single session study with a crossover design. During the study healthy participants will be randomized to either receive a injection of hypertonic saline (painful injection) or isotonic saline (control injection) in a neck muscle. Head repositioning accuracy will be assessed with and without performing a cognitive task.

Interventions

Painful condition: Participants will be injected in a neck muscle with 0.5ml of hypertonic saline (5.8%)

Control condition: Participants will be injected in a neck muscle with 0.5ml isotonic saline (0.9%)

Sponsors

The Danish Rheumatism Association
CollaboratorOTHER
Aalborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Intervention model description

Participants will be randomized to either the painful condition or the control condition first before crossing over to opposite condition.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women aged 18-50 years * Right handed * Able to speak, read and understand Danish or English * Normal pain free neck and shoulder range of motion

Exclusion criteria

* Pain from the neck or shoulder area * Prior surgery in neck or shoulder * Pregnancy * Drug addiction defined as the use of cannabis, opioids or other drugs * Self reported neurologic, musculoskeletal or mental illnesses

Design outcomes

Primary

MeasureTime frameDescription
Change in head repositioning accuracyWithin session (session lasts approximately 2 hours)Participants will be blindfolded and asked asked to, from a neutral position, to move the head into full range of motion before returning to to a neutral position again. The difference between the start and end position will be used as an estimate of head repositioning error.

Secondary

MeasureTime frameDescription
Change in perceived painWithin session (session lasts approximately 2 hours)Pain will be scored using a scale from 0-10 with 0 being no pain and 10 being worst imaginable pain, by drawing on body charts and choosing words from the McGill Pain Questionnaire.
Change in perceived performance of head repositioning accuracy testWithin session (session lasts approximately 2 hours)Likert scores of the perceived difficultness (0=no problems, 1=minimally difficult, 2=somewhat difficult, 3=fairly difficult, 4= very difficult, 5=unable to perform)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026